Cyclopentolate
RxNorm 3001
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 3001 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cyclopentolate.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Cyclopentolate
(Atom ID: 12254426)
PTPrescribable
Designated preferred name (PT):
Cyclopentolate
(Atom ID: 89980)
FNPrescribable
Full form of descriptor (FN):
Cyclopentolate (substance)
(Atom ID: 89988)
PTPrescribable
Designated preferred name (PT):
Cyclopentolate-containing product
(Atom ID: 10800532)
FNPrescribable
Full form of descriptor (FN):
Product containing cyclopentolate (medicinal product)
(Atom ID: 9723952)
Patient Education
Cyclopentolate Ophthalmic
Cyclopentolate ophthalmic is used to cause mydriasis (pupil dilation) and cycloplegia (paralysis of the ciliary muscle of the eye) before an eye examination. Cyclopentolate is in a class of medications called mydriatics. Cyclopentolate works by blocking certain receptors found in the eye to temporarily relax or provide short-term paralysis of the eye muscles.
[Learn More]
* Please review the disclaimer below.